{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:37Z","timestamp":1792857157000,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["112\\u20132320-B-030\\u2013010-MY3"],"award-info":[{"award-number":["112\\u20132320-B-030\\u2013010-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["110-CGH-FJU-02"],"award-info":[{"award-number":["110-CGH-FJU-02"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112842","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T14:12:08Z","timestamp":1722521528000},"page":"112842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["NRICM101 prevents kainic acid-induced seizures in rats by modulating neuroinflammation and the glutamatergic system"],"prefix":"10.1016","volume":"140","author":[{"given":"Chi-Feng","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Che","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jane","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112842_b0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","article-title":"Incidence of epilepsy: a systematic review and meta-analysis","volume":"77","author":"Ngugi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2024.112842_b0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1734-1140(13)71060-0","article-title":"Research advances in basic mechanisms of seizures and antiepileptic drug action","volume":"65","author":"Lason","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2024.112842_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2024.112842_b0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2024.112842_b0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.112842_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107855","article-title":"Why we urgently need improved epilepsy therapies for adult patients","volume":"170","author":"Billakota","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2024.112842_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.682821","article-title":"Chinese herbal medicine for treating epilepsy","volume":"15","author":"Lin","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155022","article-title":"Research progress on the treatment of epilepsy with traditional Chinese medicine","volume":"120","author":"Wu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.112842_b0045","first-page":"604","article-title":"Natural medicines for the treatment of Epilepsy: bioactive components, pharmacology and mechanism","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.107075","article-title":"Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy: a updated meta-analysis of randomized controlled trials","volume":"189","author":"Lu","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.intimp.2024.112842_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12463","article-title":"Medicinal compounds with antiepileptic\/anticonvulsant activities","volume":"55","author":"Zhu","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.112842_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111037","article-title":"A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study","volume":"133","author":"Tsai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112842_b0065","first-page":"56","article-title":"In Silico and In Vitro studies of taiwan chingguan yihau (NRICM101) on TNF-\u03b1\/IL-1\u03b2-induced human lung cells","volume":"12","author":"Cheng","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2024.112842_b0070","doi-asserted-by":"crossref","first-page":"15385","DOI":"10.3390\/ijms232315385","article-title":"Pharmacological mechanism of NRICM101 for COVID-19 treatments by combined network pharmacology and pharmacodynamics","volume":"23","author":"Sing","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.112842_b0075","doi-asserted-by":"crossref","first-page":"1125414","DOI":"10.3389\/fphar.2023.1125414","article-title":"NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0080","doi-asserted-by":"crossref","unstructured":"M. L\u00e9vesque, M. Avoli M, The kainic acid model of temporal lobe epilepsy, Neurosci. Biobehav. Rev. 37 (2013) 2887\u20132899.","DOI":"10.1016\/j.neubiorev.2013.10.011"},{"key":"10.1016\/j.intimp.2024.112842_b0085","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","article-title":"Neuroinflammation and proinflammatory cytokines in epileptogenesis","volume":"59","author":"Soltani Khaboushan","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.112842_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/glia.24106","article-title":"Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity","volume":"70","author":"Hotz","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2024.112842_b0100","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1039\/D2FO01490D","article-title":"Rutin prevents seizures in kainic acid-treated rats: evidence of glutamate levels, inflammation and neuronal loss modulation","volume":"13","author":"Chang","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2024.112842_b0105","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.14-05-02697.1994","article-title":"Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study","volume":"14","author":"Friedman","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0110","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1039\/D0FO02039G","article-title":"TCD, a triterpenoid isolated from wild bitter gourd, reduces synaptosomal release of glutamate and protects against kainic acid-induced neuronal death","volume":"11","author":"Hsu","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2024.112842_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electric stimulation: II. Motor seizure, EEG","volume":"32","author":"Racine","year":"1972","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.intimp.2024.112842_b0120","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3390\/molecules27092638","article-title":"Piperine provides neuroprotection against kainic acid-induced neurotoxicity via maintaining NGF signalling pathway","volume":"27","author":"Hsieh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112842_b0125","doi-asserted-by":"crossref","unstructured":"W.H. Jean, C.T. Huang, J.H. Hsu, K.M. Chiu, M.Y. Lee, J.S. Shieh, T.Y. Lin, S.J. Wang SJ, Anticonvulsive and neuroprotective effects of eupafolin in rats are associated with the inhibition of glutamate overexcitation and upregulation of the Wnt\/\u03b2-Catenin signaling pathway, ACS Chem. Neurosci. 13 (2022) 1594\u20131603.","DOI":"10.1021\/acschemneuro.2c00227"},{"key":"10.1016\/j.intimp.2024.112842_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuro.2016.05.008","article-title":"Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats","volume":"55","author":"Lin","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2024.112842_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176197","article-title":"Stabilization of mitochondrial function by chlorogenic acid protects against kainic acid-induced seizures and neuronal cell death in rats","volume":"961","author":"Pai","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0140","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1039\/C8FO02189A","article-title":"Piperine-mediated suppression of voltage-dependent Ca2+ influx and glutamate release in rat hippocampal nerve terminals involves 5HT1A receptors and G protein \u03b2\u03b3 activation","volume":"10","author":"Hsieh","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2024.112842_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2015.02.041","article-title":"Protective effect of hispidulin on kainic acid-induced seizures and neurotoxicity in rats","volume":"755","author":"Lin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2024.112842_b0155","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0140-6736(93)90754-5","article-title":"Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain","volume":"341","author":"During","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112842_b0160","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s11064-012-0766-5","article-title":"Role of glutamine synthetase inhibition in epilepsy","volume":"37","author":"Eid","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2024.112842_b0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0170","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/brain\/awv067","article-title":"Astrocyte uncoupling as a cause of human temporal lobe epilepsy","volume":"138","author":"Bedner","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2024.112842_b0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2024.112842_b0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2024.112842_b0185","article-title":"Role of HMGB1\/TLR4 and IL-1\u03b2\/IL-1R1 signaling pathways in epilepsy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2024.112842_b0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nan.12444","article-title":"Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies","volume":"44","author":"van Vliet","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.intimp.2024.112842_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175213","article-title":"Morin offsets PTZ-induced neuronal degeneration and cognitive decrements in rats: The modulation of TNF-\u03b1\/TNFR-1\/RIPK1,3\/MLKL\/PGAM5\/Drp-1, IL-6\/JAK2\/STAT3\/GFAP and Keap-1\/Nrf-2\/HO-1 trajectories","volume":"931","author":"Abd El-Aal","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112842_b0200","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.intimp.2024.112842_b0205","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s10072-023-06720-0","article-title":"Meta-analysis of HMGB1 levels in the cerebrospinal fluid and serum of patients with epilepsy","volume":"44","author":"Chen","year":"2023","journal-title":"Neurol Sci."},{"key":"10.1016\/j.intimp.2024.112842_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107138","article-title":"Serum concentration of high-mobility group box 1, Toll-like receptor 4 as biomarker in epileptic patients","volume":"192","author":"Yue","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.intimp.2024.112842_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106516","article-title":"Changes of HMGB-1 and sTLR4 levels in cerebrospinal fluid of patients with febrile seizures","volume":"169","author":"Kaya","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.intimp.2024.112842_b0220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2015.06.013","article-title":"Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats","volume":"301","author":"Soukupova","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2024.112842_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2024.112842_b0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fnmol.2017.00451","article-title":"Astroglial glutamate signaling and uptake in the hippocampus","volume":"10","author":"Rose","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13105-010-0054-2","article-title":"Decreased glutamine synthetase, increased citrulline - nitric oxide cycle activities and oxidative stress in different regions of brain in epilepsy rat model","volume":"167","author":"Swamy","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2024.112842_b0240","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/ejn.12756","article-title":"Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats","volume":"40","author":"van der Hel","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2024.112842_b0250","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2024.112842_b0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2024.112842_b0260","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0265","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1152\/jn.00448.2005","article-title":"Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons","volume":"94","author":"Kang","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.intimp.2024.112842_b0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2012.05.010","article-title":"Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy","volume":"47","author":"Perez","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2024.112842_b0275","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/jnr.21325","article-title":"Neuroinflammation and regulation of glial glutamate uptake in neurological disorders","volume":"85","author":"Tilleux","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.intimp.2024.112842_b0280","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuron.2008.04.002","article-title":"Astrocytes in the epileptic brain","volume":"58","author":"Wetherington","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2024.112842_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107742","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"167","author":"Terrone","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2024.112842_b0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12974-018-1139-z","article-title":"LncRNA H19 contributes to hippocampal glial cell activation via JAK\/STAT signaling in a rat model of temporal lobe epilepsy","volume":"15","author":"Han","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2024.112842_b0295","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s11064-011-0576-1","article-title":"Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy","volume":"36","author":"Xu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2024.112842_b0300","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: a regulated infammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinfammation"},{"key":"10.1016\/j.intimp.2024.112842_b0305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/1028415X.2016.1189057","article-title":"Resveratrol suppressed seizures by attenuating IL-1\u03b2, IL1-Ra, IL-6, and TNF-\u03b1 in the hippocampus and cortex of kindled mice","volume":"20","author":"Hoda","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.intimp.2024.112842_b0310","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/medicina59091554","article-title":"ACE2 and a traditional Chinese medicine formula NRICM101 could alleviate the inflammation and pathogenic process of acute lung injury","volume":"59","author":"Lin","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.intimp.2024.112842_b0315","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jnc.14663","article-title":"High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches","volume":"151","author":"Paudel","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2024.112842_b0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5607\/en.2013.22.2.107","article-title":"Glycyrrhizin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus","volume":"22","author":"Luo","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.intimp.2024.112842_b0325","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/WNR.0b013e328363fed3","article-title":"Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticus","volume":"24","author":"Li","year":"2013","journal-title":"Neuroreport"},{"key":"10.1016\/j.intimp.2024.112842_b0330","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2024.112842_b0335","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1211\/002235702522","article-title":"Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats","volume":"55","author":"Lai","year":"2003","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.intimp.2024.112842_b0340","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1142\/S0192415X1650052X","article-title":"Baicalein, a constituent of Scutellaria baicalensis, reduces glutamate release and protects neuronal cell against kainic acid-induced excitotoxicity in rats","volume":"44","author":"Chang","year":"2016","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.intimp.2024.112842_b0345","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2147\/DDDT.S314076","article-title":"Baicalin rescues cognitive dysfunction, mitigates neurodegeneration, and exerts anti-epileptic effects through activating TLR4\/MYD88\/caspase-3 pathway in rats","volume":"15","author":"Yang","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2024.112842_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147723","article-title":"Pei L, Baicalin suppresses neuron autophagy and apoptosis by regulating astrocyte polarization in pentylenetetrazol-induced epileptic rats and PC12 cells","volume":"1774","author":"Li","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2024.112842_b0355","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fphar.2019.00638","article-title":"Baicalein exerts neuroprotective effects in FeCl3-induced posttraumatic epileptic seizures via suppressing ferroptosis","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:00:16Z","timestamp":1786363216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":71,"alternative-id":["S1567576924013638"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112842","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NRICM101 prevents kainic acid-induced seizures in rats by modulating neuroinflammation and the glutamatergic system","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112842"}}